Revenue + Forward P/E
Thermo Fisher Scientific Inc. (TMO) quarterly revenue and forward P/EForward P/E: 23.0x
RevenueRevenue (est)Forward P/E
Fair value & valuation models
Fair value models are a Plus feature
Upgrade to Plus for the interactive DCF model, valuation bands, and implied-price scenarios.
71% OFF$23.99 $6.99/mo
Ends in23:59:59
Cancel anytime. Secure checkout via Stripe.
Valuation
Market cap
$223.44B
Enterprise value
$249.66B
P/E ratio (TTM)
30.52x
P/S ratio (TTM)
4.56x
P/B ratio
4.00x
EV/Sales
5.39x
EV/EBITDA
22.83x
Dividend yield
0.32%
Income statement (TTM)
Revenue (TTM)
$44.56B
Gross profit (TTM)
$16.78B
Operating income (TTM)
$8.11B
EBITDA (TTM)
$11.47B
Net income (TTM)
$6.74B
Free cash flow (TTM)
$6.29B
Margins & returns
Gross margin
40.37%
Operating margin
17.69%
Profit margin
15.06%
Return on equity
13.35%
Return on assets
6.17%
Per-share metrics
EPS (TTM)
$18.81
Dividend yield
0.32%
Beta
0.87
Capital structure
Cash & equivalents
$9.86B
Total debt
$40.85B
Net debt
$31.00B
Shares outstanding
371.62M
Financial health
Current ratio
1.89
Debt / equity
0.76
Debt / assets
0.37
Interest coverage
5.71
| Company | Market cap | P/E | P/S | EV/EBITDA | Div yield |
|---|---|---|---|---|---|
| $1.15T | 42.41x | 15.59x | 34.80x | 0.54% | |
| $630.77B | 30.45x | 6.47x | 20.76x | 1.99% | |
| $442.76B | 127.13x | 7.29x | 30.82x | 2.63% | |
| $365.75B | 27.06x | 0.85x | 16.46x | 2.13% | |
| $355.30B | 23.91x | 4.80x | 15.14x | 2.67% | |
| $332.96B | 36.82x | 4.94x | 19.57x | 2.56% | |
| $223.44B | 30.52x | 4.56x | 22.83x | 0.32% |